Sven A. Lang
- Molecular Biology top 10%
- Oncology top 10%
- Cancer Research top 10%
- Immunology top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Edward K. GeisslerHans J. SchlittOliver StoeltzingChristian MoserAndreas GäumannClaus HellerbrandGabriel GlockzinDagmar Klein
- Topics
- Cancer, Hypoxia, and Metabolism (12 papers)Heat shock proteins research (11 papers)Angiogenesis and VEGF in Cancer (8 papers)
- Partner nations
- GermanyUnited StatesChina
In The Last Decade
Sven A. Lang
43 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 94
- Molecular Biology 928
- Oncology 449
- Cancer Research 298
- Immunology 218
- Pulmonary and Respiratory Medicine 174
Countries citing papers authored by Sven A. Lang
This map shows the geographic impact of Sven A. Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven A. Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven A. Lang more than expected).
Fields of papers citing papers by Sven A. Lang
This network shows the impact of papers produced by Sven A. Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven A. Lang. The network helps show where Sven A. Lang may publish in the future.
Co-authorship network of co-authors of Sven A. Lang
This figure shows the co-authorship network connecting the top 25 collaborators of Sven A. Lang. A scholar is included among the top collaborators of Sven A. Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven A. Lang. Sven A. Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 7 | |
| 5 | 35 | |
| 6 | 33 | |
| 7 | 7 | |
| 8 | 11 | |
| 9 | 90 | |
| 10 | 42 | |
| 11 | 65 | |
| 12 | 61 | |
| 13 | 13 | |
| 14 | 49 | |
| 15 | 62 | |
| 16 | Targeting Hsp90 using EC154, a novel synthetic Hsp90 inhibitor, impairs multiple oncogenic signaling pathways in human gastric and pancreatic cancer cells and reduces tumor growth in vivo | 1 |
| 17 | 95 | |
| 18 | 138 | |
| 19 | 8 | |
| 20 | 17 |
About Sven A. Lang
Sven A. Lang is a scholar working on Cancer Research, Molecular Biology and Hepatology, having authored 44 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (12 papers), Heat shock proteins research (11 papers) and Angiogenesis and VEGF in Cancer (8 papers). The work is most often cited by research in Cancer Research (298 citations), Oncology (449 citations) and Molecular Biology (928 citations). Sven A. Lang has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Edward K. Geissler, Hans J. Schlitt, Oliver Stoeltzing, Christian Moser, Andreas Gäumann, Claus Hellerbrand, Gabriel Glockzin, Dagmar Klein, Akira Mori and Christina Hackl. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.